Autorisation d’accès précoce refusée à la spécialité ZURZUVAE (zuranolone) dans l'indication « traitement de la dépression sévère du post-partum (DPP) suivant l’accouchement chez les adultes. »
See also
HAS opinions and decisions
23/06/2025
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
pLMze5xLGVdnkgEn
